This trial addresses the clinical question of whether oral therapy can serve as a sustainable long-term maintenance strategy after initial injectable treatment, a paradigm that could significantly influence treatment algorithms and reduce long-term healthcare costs
Kolterman OG, Kim DD, Shen L, Ruggles JA, Nielsen LL, Fineman MS, Baron AD
Hua et al., 2002)
As with any therapeutic intervention, it's crucial to consult with medical professionals for personalized guidance and to ensure safe and effective usage of BPC-157.
It is not approved for human or animal use and must not be incorporated into foods, cosmetics, medications, or diagnostic procedures
Moreover, miR-483-3p is identified as a critical regulator of IGF-1 expression in natural killer cells